戻る Agenda
Session 9 Plenary: AI: Investments and Future Outcomes
Session Chair(s)
Oxana Iliach, PhD
Senior Director Regulatory Strategy, Certara, Canada
Marcia Sam
Senior Manager, Regulatory Affairs, Regeneron Canada Company, Canada
This session will provide an overview of Health Canada current view on use of AI and potential future outcomes.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe potential use of AI
- Discuss investments in AI development
- Explain latest Health Canada expectations for AI outcomes
Speaker(s)
Kelly Robinson, MSc
Director General, Pharmaceutical Drugs Directorate, Health Canada, Canada
AI: Regulatory Reflections
Myriam Salem, MSc
National Supervisor, Regulatory Operations and Enforcement Branch, Health Canada, Canada
PIC/S Working Group on AI: International Collaboration of Pharmacovigilance Inspectors
James Van Loon
Chief Data Officer, Digital Transformation Branch , Health Canada, Canada
Leveraging AI at Health Canada (HC)